Viking Therapeutics, Inc.
Total Trades
102
Buys
2
Sells
50
Largest Trade
N/A
Insiders
8
Institutional Funds
348
Inst. Value
$1M+
Activist Filings
25
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ZANTE GREG | CFO | GRANT | N/A | 28K | — | Jul 31, 2024 |
| ZANTE GREG | CFO | SELL | $500K+ | 16K | $57.15 | Jul 31, 2024 |
| Lian Brian | President & CEO | SELL | $1M+ | 116K | $57.58 | Jul 31, 2024 |
| Mancini Marianna | COO | GRANT | N/A | 32K | — | Jul 31, 2024 |
| Mancini Marianna | COO | SELL | $1M+ | 18K | $57.13 | Jul 31, 2024 |
| Lian Brian | President & CEO | GRANT | N/A | 204K | — | Jul 31, 2024 |
| ZANTE GREG | CFO | EXERCISE | $100K–$500K | 34K | $4.86 | May 4, 2024 |
| ZANTE GREG | CFO | SELL | $1M+ | 67K | $74.69 | May 4, 2024 |
| Mancini Marianna | COO | SELL | $1M+ | 281K | $78.66 | May 3, 2024 |
| Mancini Marianna | COO | EXERCISE | $1M+ | 281K | $6.18 | May 3, 2024 |
| Lian Brian | President & CEO | SELL | $1M+ | 45K | $29.90 | Feb 10, 2024 |
| Lian Brian | President & CEO | SELL | $1M+ | 269K | $26.87 | Feb 9, 2024 |
| Lian Brian | President & CEO | EXERCISE | $500K+ | 189K | $3.76 | Feb 9, 2024 |
| Rouan Sarah Kathryn | Director | SELL | $500K+ | 25K | $28.05 | Feb 9, 2024 |
| Rouan Sarah Kathryn | Director | EXERCISE | $100K–$500K | 25K | $8.32 | Feb 9, 2024 |
| Lian Brian | President & CEO | SELL | $1M+ | 85K | $24.71 | Feb 1, 2024 |
| Lian Brian | President & CEO | EXERCISE | $100K–$500K | 85K | $1.23 | Feb 1, 2024 |
| Lian Brian | President & CEO | EXERCISE | $15K–$50K | 35K | $1.23 | Jan 31, 2024 |
| Lian Brian | President & CEO | SELL | $500K+ | 35K | $23.95 | Jan 31, 2024 |
| Rouan Sarah Kathryn | Director | EXERCISE | $100K–$500K | 30K | $8.32 | Jan 20, 2024 |
| Rouan Sarah Kathryn | Director | SELL | $500K+ | 30K | $23.05 | Jan 20, 2024 |
| ZANTE GREG | CFO | SELL | $100K–$500K | 15K | $17.90 | Jan 5, 2024 |
| ZANTE GREG | CFO | GRANT | N/A | 98K | — | Jan 5, 2024 |
| Rowland Charles A Jr | Director | SELL | $1M+ | 40K | $25.00 | May 18, 2023 |
| Rowland Charles A Jr | Director | EXERCISE | $15K–$50K | 40K | $1.08 | May 18, 2023 |
| MACARTNEY LAWSON | Director | SELL | $100K–$500K | 16K | $24.00 | May 18, 2023 |
| MACARTNEY LAWSON | Director | EXERCISE | $15K–$50K | 16K | $1.19 | May 18, 2023 |
| Lian Brian | President & CEO | SELL | $1M+ | 45K | $22.45 | May 1, 2023 |
| MACARTNEY LAWSON | Director | SELL | $100K–$500K | 16K | $22.00 | Apr 24, 2023 |
| MACARTNEY LAWSON | Director | EXERCISE | $50K–$100K | 16K | $3.33 | Apr 24, 2023 |
| Lian Brian | President & CEO | SELL | $500K+ | 35K | $21.45 | Apr 21, 2023 |
| MACARTNEY LAWSON | Director | EXERCISE | $100K–$500K | 21K | $8.00 | Apr 18, 2023 |
| MACARTNEY LAWSON | Director | SELL | $100K–$500K | 21K | $20.00 | Apr 18, 2023 |
| Lian Brian | President & CEO | SELL | $1M+ | 155K | $20.45 | Apr 18, 2023 |
| Lian Brian | President & CEO | EXERCISE | $100K–$500K | 125K | $2.15 | Apr 18, 2023 |
| Mancini Marianna | COO | SELL | $100K–$500K | 13K | $20.00 | Apr 18, 2023 |
| Mancini Marianna | COO | EXERCISE | $100K–$500K | 13K | $13.07 | Apr 18, 2023 |
| ZANTE GREG | CFO | SELL | $100K–$500K | 8K | $20.00 | Apr 18, 2023 |
| ZANTE GREG | CFO | EXERCISE | $50K–$100K | 8K | $13.07 | Apr 18, 2023 |
| Lian Brian | President & CEO | EXERCISE | $100K–$500K | 54K | $1.88 | Apr 13, 2023 |
| Lian Brian | President & CEO | SELL | $1M+ | 79K | $18.45 | Apr 13, 2023 |
| ZANTE GREG | CFO | SELL | $1M+ | 98K | $18.00 | Apr 13, 2023 |
| ZANTE GREG | CFO | EXERCISE | $500K+ | 98K | $5.57 | Apr 13, 2023 |
| Lian Brian | President & CEO | GRANT | N/A | 300K | — | Apr 3, 2023 |
| Lian Brian | President & CEO | SELL | $1M+ | 243K | $17.31 | Apr 3, 2023 |
| Lian Brian | President & CEO | EXERCISE | $500K+ | 203K | $4.78 | Apr 3, 2023 |
| ZANTE GREG | CFO | GRANT | N/A | 57K | — | Apr 3, 2023 |
| ZANTE GREG | CFO | SELL | $1M+ | 162K | $17.19 | Apr 3, 2023 |
| ZANTE GREG | CFO | EXERCISE | $500K+ | 125K | $7.41 | Apr 3, 2023 |
| Mancini Marianna | COO | SELL | $1M+ | 238K | $15.17 | Mar 31, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 348 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 4.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 993K | $1M+ | SH |
| Pictet Asset Management Holding SA | 753K | $1M+ | SH |
| Artia Global Partners LP | 719K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 700K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 519K | $1M+ | SH |
| BARCLAYS PLC | 517K | $1M+ | SH |
| PRINCIPAL FINANCIAL GROUP INC | 511K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 503K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 500K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 449K | $1M+ | SH |
| Clearbridge Investments, LLC | 445K | $1M+ | SH |
| RAYMOND JAMES FINANCIAL INC | 441K | $1M+ | SH |
| First Washington CORP | 388K | $1M+ | SH |
| STIFEL FINANCIAL CORP | 337K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 330K | $1M+ | SH |
| Steward Partners Investment Advisory, LLC | 316K | $1M+ | SH |
| Point72 Asset Management, L.P. | 313K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 305K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 5, 2025
5.1%
5.8M shares
SC 13G/A · Aug 6, 2025
8.7%
9.8M shares
SC 13G/A · May 12, 2025
10.0%
11.2M shares
SC 13G/A · Apr 23, 2025
4.5%
5.0M shares
SC 13G · Feb 4, 2025
5.3%
5.9M shares
SC 13G/A · Nov 14, 2024
0.6%
722K shares
SC 13G/A · Nov 12, 2024
9.2%
10.2M shares
SC 13G/A · Nov 4, 2024
9.2%
10.2M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 18, 2024
4.2%
4.7M shares
SC 13G/A · Aug 7, 2024
4.9%
5.5M shares
SC 13G/A · Feb 14, 2024
5.1%
5.1M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.4%
5.4M shares
SC 13G · Jan 26, 2024
7.6%
7.6M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 24, 2024
5.7%
0 shares
SC 13G/A · Jan 12, 2024
0.4%
404K shares
SC 13G · Nov 2, 2023
5.9%
5.9M shares
SC 13G · Apr 10, 2023
11.4%
10.9M shares
Ligand Pharmaceuticals Incorporated
SC 13D/A · Mar 30, 2023
4.6%
3.6M shares
ArrowMark Colorado Holdings, LLC
SC 13G/A · Feb 14, 2023
0.0%
16K shares
Ligand Pharmaceuticals Incorporated
SC 13D/A · Feb 9, 2023
7.9%
6.1M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 3, 2023
0.3%
0 shares
SC 13G · Jan 3, 2023
6.3%
4.8M shares
SC 13G · Jul 8, 2022
1.8%
1.4M shares
ArrowMark Colorado Holdings, LLC
SC 13G/A · Feb 14, 2022
9.0%
7.1M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 12, 2022
5.3%
0 shares